SNDX — SYNDAX PHARMACEUTICALS INC

Ownership history in STEMPOINT CAPITAL LP  ·  12 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in SYNDAX PHARMACEUTICALS INC (SNDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
9.98% (2024 Q3)
Avg. % of fund
5.31%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,339,379 +1,239,379 +1239.4% 4.83% $28.1M $21.01
2025 Q3 REDUCED 100,000 -1,266,205 -92.7% 0.01% $55K $15.39
2025 Q3 REDUCED 1,366,205 -1,006,429 -42.4% 4.21% $21.0M $15.39
2025 Q2 ADDED 2,372,634 +774,040 +48.4% 7.13% $22.2M $9.36
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SNDX price (monthly, adj. close)

Other funds also holding SNDX

As of 2025 Q4 — sorted by position size

Elmind Capital, LP 11.5% Kynam Capital Management, LP 3Y 10.81% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 5.87% Aisling Capital Management LP 3Y 7Y 5.78% Catalio Capital Management, LP 4.44% Knott David M Jr 3Y 4.04% Lion Point Capital, LP 3Y 7Y 3.91% Eversept Partners, LP 3Y 7Y 3.51% MPM BioImpact LLC 3Y 3.22% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 3.1%
← Back to STEMPOINT CAPITAL LP Holdings